Last edition
News about "Ipsen Withdraws Drug In US"
Hutchmed Initiates Tazverik Recall In China After Ipsen Withdraws Drug In US
Hutchmed (China) Limited has begun withdrawing the cancer therapy Tazverik (tazemetostat) from markets in mainland China, Hong Kong and Macau after its partner Ipsen decided to voluntarily remove the drug from the US market.
Ipsen Withdraws Drug In US | 11/03/2026 | By Darshana | 102
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members